ADAR1 Capital Management »

Maravai Lifesciences Holdings shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Maravai Lifesciences Holdings (MRVI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Maravai Lifesciences Holdings

Tip: Access up to 7 years of quarterly data

All positions including Maravai Lifesciences Holdings held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maravai Lifesciences Holdings by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.7k 1.0k 8.67

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Maravai Lifesciences Holdings

GTCR
12 West Capital Management
Vanguard Group
BlackRock
BlackRock
Braidwell
Mackenzie Financial
Renaissance Technologies
Jpmorgan Chase & Co
Massachusetts Financial Services
Jennison Associates
State Street Corporation
Geode Capital Management
Point72
Glenmede Trust Company

View all funds holding Maravai Lifesciences Holdings